Durham, NC, United States of America

William P Sheridan

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: William P. Sheridan: Innovator in Viral Treatment

Introduction

William P. Sheridan is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of viral infections. With a total of 2 patents, his work focuses on innovative methods and compositions aimed at combating serious health threats.

Latest Patents

Sheridan's latest patents include groundbreaking research on methods, compositions, and dosing regimens for the treatment of SARS-CoV-2 infections. This patent provides compounds characterized by favorable pharmacokinetics for the active pharmaceutical ingredient, particularly when administered through a novel dosing regimen. Additionally, he has developed anti-influenza compositions and methods that involve novel compounds linked to carbocycles or heterocycles. These compositions are designed to inhibit, treat, and suppress viral infections effectively.

Career Highlights

Throughout his career, Sheridan has worked with prominent companies in the pharmaceutical industry, including Biocryst Pharmaceuticals, Inc. and Island Pharmaceuticals Ltd. His experience in these organizations has allowed him to contribute to significant advancements in antiviral therapies.

Collaborations

Sheridan has collaborated with esteemed colleagues such as Shanta Bantia and Pravin L. Kotian. These partnerships have further enhanced his research and development efforts in the field of viral treatment.

Conclusion

William P. Sheridan stands out as an influential inventor whose work in antiviral treatments has the potential to make a lasting impact on public health. His innovative approaches and collaborations continue to drive advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…